2017 LeIP Front Page banner

The Lymphoma Coalition (LC) continues its quest to improve access to therapy, including clinical trials, in a timely and cost-effective manner for all patients with lymphoma. However, through discussions with LC member countries and findings from the 2016 Lymphoma Global Patient Survey (GPS), LC has identified four impediments that need to be addressed to improve therapy access.

Four impediments that need to be addressed to improve therapy access are:

  1. Unequal access to clinical trials;
  2. No or limited funding/reimbursement of therapies, in particular innovative therapies;
  3. Limited supportive care;
  4. Limited access to specialists and treatment centres.

The 2017 Report Card on Lymphomas will demonstrate how the impediments in providing timely and cost-effective care have a negative effect on the well-being of patients. The report card will also review, through case studies, what initiatives member countries have undertaken to improve or remove these impediments.

Download the 2017 LeIP Report Card on Lymphomas here.


Global Database

Information by country, region and/or subtype on treatments, clinical trials and incidence/mortality rates.

Resource Library

Over 2,000 pieces of information on lymphoma diagnosis, treatment, research, support and lifestyle.

logo europe




The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or
require more detailed information on the best course of treatment for you.

Our website does not host any form of advertisement. Last updated: 02/19/19. Copyright © 2018 Lymphoma Coalition. All rights reserved.